SCHEMBL21160462

SCHEMBL21160462

CN(CCO)c1cc2sc(/C=C(\C#N)C(=O)O)cc2s1

nearest known ligand 0.39

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 2/20 0.34
LMNA P02545 1/20 0.34
ATM Q13315 1/20 0.34
EGFR P00533 2/20 0.34
SLC16A3 O15427 1/20 0.34
SLC16A1 P53985 1/20 0.34
CISD1 Q9NZ45 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22295850 0.85 MAPT (0.39) MAPTKDM4EEGFRSLC16A3SLC16A1
SCHEMBL21036998 0.85 RPS6KA3 (0.36) MAPT
SCHEMBL21234738 0.81 ATM (0.35) MAPTPOLBKDM4ELMNAATM
SCHEMBL21234731 0.81 EGFR (0.33) MAPTPOLBKDM4ELMNAATM
SCHEMBL21234732 0.80 MAPT (0.32) MAPTPOLBKDM4ELMNAATM
SCHEMBL22313935 0.80 APP (0.41) MAPTSLC16A3SLC16A1
SCHEMBL21160414 0.78 MAPT (0.52) MAPTKDM4EEGFRSLC16A3SLC16A1
SCHEMBL21234689 0.77 MAPT (0.36) MAPTPOLBKDM4ELMNAATM
SCHEMBL21036993 0.76 CYP2A6 (0.35) KDM4E
SCHEMBL23171480 0.75 SIGMAR1 (0.31) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11209437-B2 Fluorescent probe and preparation method and use thereof FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) 2021-12-28 US disclosed
US-20200248069-A1 FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-08-06 US disclosed
US-20190187144-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190187144-A1 FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF HNRNPF, HNRNPUL2, RAB5IF MAPT 2624/4885POLB 2809/4885KDM4E 4671/4885
US-20200248069-A1 FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF WASF2, FAM162A, HASPIN MAPT 3407/4885POLB 3374/4885KDM4E 4770/4885
US-11209437-B2 Fluorescent probe and preparation method and use thereof HNRNPF, HNRNPUL2, RAB5IF MAPT 2624/4885POLB 2809/4885KDM4E 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.